Jame Abraham, Chairman and Professor at the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a post on X about a paper by Badi El Osta et al. published in JCO Oncology Practice:
“What is on the Horizon Beyond Platinum and Immunotherapy for Patients With Advanced Non–Small Cell Lung Cancer Without Actionable Genomic Aberrations?”
Title: What is on the Horizon Beyond Platinum and Immunotherapy for Patients With Advanced Non–Small Cell Lung Cancer Without Actionable Genomic Aberrations?
Authors: Amanda Ribeiro Rangel, Gabriel Cavalcante Lima Chagas, Rafael Cavalcante Lima Chagas, Badi El Osta
You can read the full article in JCO Oncology Practice.
More posts about NSCLC.